6
Views
19
CrossRef citations to date
0
Altmetric
Original Article

300 Mg Nizatidine at Night versus 300 Mg Ranitidine at Night in Patients with Duodenal Ulcer: A Multicentre Trial in Europe

, , , , , , & show all
Pages 61-70 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

S. K. Lam. (1990) Why Do Ulcers Heal with Sucralfate?. Scandinavian Journal of Gastroenterology 25:sup173, pages 6-16.
Read now
P. G. Farup, A. R. Rosseland, L. Halvorsen, O. K. Andersen & T. Bernklev. (1989) Duodenal Ulcer Treated with Omeprazole: Healing and Relapse Rates. Scandinavian Journal of Gastroenterology 24:9, pages 1107-1112.
Read now
P. Bauerfeind, H. R. Koelz & A. L. Blum. (1988) Ulcer Treatment–Regimens and Duration of Inhibition of Acid Secretion: How Long to Dose. Scandinavian Journal of Gastroenterology 23:sup153, pages 23-34.
Read now

Articles from other publishers (16)

Domenico Simeone, Maria Cristina Caria, Erasmo Miele & Annamaria Staiano. (1997) Treatment of Childhood Peptic Esophagitis: A Double-Blind Placebo-Controlled Trial of Nizatidine. Journal of Pediatric Gastroenterology &amp Nutrition 25:1, pages 51-55.
Crossref
Susan C. Kalish, Rhonda L. Bohn & Jerry Avorn. (1997) Policy Analysis of the Conversion of Histamine2 Antagonists to Over-the-Counter Use. Medical Care 35:1, pages 32-48.
Crossref
ABR THOMSON, P. KIRDEIKIS, F. JAMALI, M. TAVERNINI, L. ZUK, B. MARRIAGE, I. SIMPSON & V. MAHACHAI. (2008) Effect of nizatidine and ranitidine on 24 hour intragastric pH, pepsin, prostaglandin E 2 and serum gastrin concentrations in healthy volunteers . Journal of Gastroenterology and Hepatology 10:5, pages 546-554.
Crossref
D. W. PIPER & D. STIEL. (2008) Nizatidine and acid‐pepsin related gastrointestinal disease. Journal of Gastroenterology and Hepatology 10:2, pages 205-207.
Crossref
TSENG‐SHING CHEN, FULL‐YOUNG CHANG & SHOU‐DONG LEE. (2008) A single standard nocturnal dose of nizatidine enhances the healing of active duodenal ulcers among Chinese. Journal of Gastroenterology and Hepatology 10:2, pages 135-139.
Crossref
G. BATTAGLIA, F. DI MARIO, S. VIGNERI, P. DAL SANTO, A. PILOTTO & G. MAZZACCA. (2007) Peptic ulcer in the elderly—a double‐blind, short‐term study comparing nizatidine 300 mg with ranitidine 300 mg. Alimentary Pharmacology & Therapeutics 7:6, pages 643-648.
Crossref
F. Di Mario, G. Battaglia, A. Saggioro, A. D'Angelo, P. Dotto, M. Ferrana, F. Vianello, A.G. Grasso, N. Dal Bo, G. Del Favero & M. Voi. (1993) H2 antagonists and gastric ulcer: A multicenter, randomized, double-blind, controlled study comparing nizatidine with ranitidine. Current Therapeutic Research 54:5, pages 572-579.
Crossref
R. L. McISAAC, J. S. DIXON, J. G. MILLS & J. R. WOOD. (2007) Ranitidine in the treatment of duodenal ulcer disease: relationship between antisecretory effect and ulcer healing rate. Alimentary Pharmacology & Therapeutics 5:3, pages 227-243.
Crossref
John A. Oates, Alastair J.J. Wood, Mark Feldman & Michael E. Burton. (1990) Histamine 2 -Receptor Antagonists . New England Journal of Medicine 323:25, pages 1749-1755.
Crossref
R. F. P. QUIK, M. J. COOPER, M. GLEESON, E. HENTSCHEL, K. SCHUETZE, R. D. KINGSTON & M. MITCHELL. (2007) A comparison of two doses of nizatidine versus placebo in the treatment of reflux oesophagitis. Alimentary Pharmacology & Therapeutics 4:2, pages 201-211.
Crossref
I. Hindmarch & S. Gilburt. (2004) The lack of CNS effects of nizatidine, with and without alcohol, on psychomotor ability and cognitive function. Human Psychopharmacology: Clinical and Experimental 5:1, pages 25-32.
Crossref
Timothy J. Wozniak. 1990. 397 427 .
G M Fullarton, G McLauchlan, A Macdonald, G P Crean & K E McColl. (1989) Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist.. Gut 30:4, pages 449-454.
Crossref
Rudolf Arnold, Hanns-Gerd Dammann, Peter Minartz, Hans-Dieter Peters & Bernd Simon. 1989. Nizatidin. Nizatidin 83 92 .
Roy Pounder. (1988) Histamine H2-receptor antagonists. Baillière's Clinical Gastroenterology 2:3, pages 593-608.
Crossref
. (1988) TOO MANY H2 ANTAGONISTS. The Lancet 331:8575-8576, pages 28-29.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.